Inhibition of Neutrophil Serine Proteinases by Suramin
Suramin, a hexasulfonated naphtylurea recently used as an anti-tumor drug, is a potent inhibitor of human neutrophil elastase, cathepsin G, and proteinase 3. The complexes it forms with these enzymes are partially active on synthetic substrates, but full inhibition takes place when elastase activity...
Saved in:
Published in | The Journal of biological chemistry Vol. 272; no. 15; pp. 9950 - 9955 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Biochemistry and Molecular Biology
11.04.1997
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Suramin, a hexasulfonated naphtylurea recently used as an anti-tumor drug, is a potent inhibitor of human neutrophil elastase,
cathepsin G, and proteinase 3. The complexes it forms with these enzymes are partially active on synthetic substrates, but
full inhibition takes place when elastase activity is measured with fibrous elastin or when cathepsin G activity is measured
using platelet aggregation. One molecule of elastase binds four molecules of suramin with a K i of 2 Ã 10 â7 M as determined by enzyme inhibition or intrinsic fluorescence enhancement of suramin. The binding curves show no sign of cooperativity
or anticooperativity. The K i for the complexes with cathepsin G and proteinase 3 are 8 Ã 10 â8 and 5 Ã 10 â7 M , respectively. Ionic strength increases the K i of the elastase-suramin complex in a way that suggests that four of the six sulfonate groups of suramin form ionic interactions
with basic residues of the enzyme and that at saturation almost all arginines of elastase form salt bridges with suramin.
The neutrophil proteinase-inhibitory activity of suramin might be used to prevent tissue destruction and thrombus formation
in diseases where massive infiltration and activation of neutrophils take place. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.272.15.9950 |